Related Experiment Video
Updated: May 3, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
5.3K
Do we need new treatments for type 2 diabetes?
Fernando Gomez-Peralta1, Cristina Abreu Padín1
1Unidad de Endocrinología y Nutrición, Hospital General de Segovia, Segovia, España.
Summary
Current type 2 diabetes mellitus treatments face challenges with effectiveness and adherence due to adverse events. New therapies are needed to preserve beta cell function and offer long-term, personalized solutions for diabetes management.
Area of Science:
- Endocrinology and Metabolism
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) presents diverse clinical scenarios and a dynamic natural history.
- Patient-specific factors significantly influence the efficacy and safety of T2DM medications.
Purpose of the Study:
- To evaluate the current limitations of T2DM pharmacotherapy.
- To identify the need for novel therapeutic agents in T2DM management.
Main Methods:
- Review of current pharmacological approaches for T2DM.
- Analysis of clinical outcomes, including macrovascular complications and adverse events.
- Assessment of impact on beta cell mass and function.
Main Results:
- Modern T2DM drugs offer expanded options but show limited clinical effectiveness.
- Key goals like reducing macrovascular complications are not fully achieved.
- Frequent adverse events (hypoglycemia, weight gain) impair treatment adherence.
- Existing treatments fail to sustain long-term beta cell mass/function.
Conclusions:
- There is a critical need for innovative T2DM drugs.
- Future therapies must provide sustainable, long-term solutions.
- New drugs should accommodate individual patient circumstances and preferences for improved diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:36Carbohydrate Metabolism
10.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28